BioSpace News Archive

Issue Names SmartMark Communications Top Utility Tech Provider 2019

Arterys was ranked second among companies in Fast Company’s Biotech innovators category.

Fifteen Therapy Dog Teams Join the Welcome Team Volunteer Program at Canada’s Largest Airport

Belgian scientist recognized for his research in cancer genomics

Berkeley Lights, Inc., a leader in digital cell biology, announced that it has been named one of Fast Company’s 2019 Most Innovative Companies in Biotech.

On Wednesday, February 27, 2019, Cardiovascular Systems’ (NASDAQ: CSII) Chairman, President and Chief Executive Officer, Scott Ward, and Chief Operating Officer, Rhonda Robb, will present at the 8th Annual SVB Leerink Global Healthcare Conference at 3:00 p.m. Eastern Time.

BiomX Ltd., a microbiome company developing customized phage therapies, today announced the closing of a $32 million series B equity financing.

Neuspera Medical Inc., a clinical stage, private venture capital backed neuromodulation company, announced the final closing (2nd tranche) of the company’s Series B equity financing.

Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, has achieved a key milestone in its progress to first-in-human testing with the commencement of a toxicology safety study of its lead nanoparticle formulation for the detection of HER2 metastatic breast cancer.

Valeo Pharma Inc. a Canadian specialty pharmaceutical company, is pleased to announce the listing and trading of its shares on the Canadian Securities Exchange under the symbol “VPH”.